Vipadenant Withdrawn Phase 2 Trials for Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00451815BIIB014 Phase 2a Monotherapy